Hikal Q3 Results

  • BSE: 524735
  • NSE: HIKAL
  • ISIN: INE475B01022
  • Sector: Biotechnology & Drugs
BSE
394.13.35 (0.86%)
Volume14.72 K
Updated: Mon 25 Nov, 2024 | 15:29:28
NSE
395.754.70 (1.20%)
Volume2.94 L
Updated: Mon 25 Nov, 2024 | 15:40:09
Today: 389.25
400.40
52-Wk: 260.65
416.15

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Hikal Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 447.57434.88-%540.20-%
    Selling/ General/ Admin Expenses Total 61.3161.81-%63.28-%
    Depreciation/ Amortization 28.9728.57-%28.27-%
    Other Operating Expenses Total 114.68102.43-%119.09-%
    Total Operating Expense 411.78405.93-%493.89-%
    Operating Income 35.7928.95-%46.31-%
    Net Income Before Taxes 21.6116.86-%35.79-%
    Net Income 16.1412.57-%26.41-%
    Diluted Normalized EPS 1.311.02-%2.14-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts